Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lysosomes are membrane-bound organelles within antigen-presenting cells (APCs) such as dendritic cells, macrophages, and B lymphocytes. They play a **critical role in the degradation of internalized antigens**—whether from pathogens or other sources—by breaking them down into peptide fragments. These peptides are then loaded onto major histocompatibility complex class II (MHC-II) molecules within the endo/lysosomal compartment before being presented on the cell surface for recognition by CD4+ T cells[1][2][5]. In some cross-presentation pathways, lysosomes also contribute to loading peptides onto MHC-I molecules[2]. Lysosome function is tightly regulated during immune responses. For example, upon stimulation with signals like lipopolysaccharide (LPS), lysosomes undergo morphological changes such as tubulation and expansion via mTOR-dependent pathways; this enhances their capacity for antigen processing and presentation[4][5][7]. The positioning of lysosomes within APCs is dynamically controlled to optimize phagocytosis and subsequent antigen presentation[5]. Dysregulation of lysosome function can impact immunity—for instance, excessive leakage can trigger inflammasome activation and inflammatory cell death[2], while altered trafficking may affect efficiency of antigen presentation. **Note:** "Lysosome function in antigen-presenting cells" refers to an organelle's activity rather than a discrete molecular target like a receptor or enzyme. It is not considered a canonical therapeutic target but rather describes an essential cellular process involving multiple proteins and regulatory mechanisms. Therefore, it does not fit standard drug-target classification schemes used for receptors or enzymes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lysosome function in antigen-presenting cell.